A correlation study of the relationships between nonalcoholic fatty liver disease and serum triglyceride concentration after an oral fat tolerance test

Table 4 Comparison of the characteristics of the NFTG and HFTG

	Total	NFTG	HFTG	P
	n = 472	n = 322	n = 150	P
Age	44 ± 13	43 ± 14	47 ± 11	0.176
Sex(male/female)	224/248	133/189	91/59	0.084
BMI	25.93 ± 4.05	24.94 ± 3.76	28.06 ± 3.85^**	< 0.001
FBG	5.41 (5.07,5.87)	5.32 (5.00,5.73)	5.60 (5.34,6.31) ^**	< 0.001
FINS	10.65 (7.35,15.24)	9.55 (6.59,12.72)	13.85 (10.20,18.83) ^**	< 0.001
HOMA-IR	2.60 (1.70,3.82)	2.24 (1.52,3.11)	3.70 (2.60,5.07) ^**	< 0.001
TC	4.72 ± 1.01	4.50 ± 0.93	5.19 ± 1.02^**	< 0.001
TG	1.66 ± 1.31	1.04 ± 0.32	2.98 ± 1.62^**	< 0.001
HDL-C	1.25 ± 0.28	1.30 ± 0.28	1.14 ± 0.24^**	< 0.001
LDL-C	2.98 ± 0.73	2.82 ± 0.69	3.32 ± 0.70^**	< 0.001
NAFLD	155 (32.8%)	64 (19.9%)	91 (60.7%) ^**	< 0.001
Non-NAFLD	317 (67.2%)	258 (80.1%)	59 (39.3%)	< 0.001

Data are mean ± standard deviation, median (interquartile range), or number (percentage)
Abbreviations NFTG normal fasting triglyceride group, HFTG High fasting triglyceride group, BMI body mass index, FBG fasting blood glucose, FINS fasting plasma insulin concentration, HOMA-IR homeostasis model assessment of insulin resistance, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein-cholesterol, LDL-C low-density lipoprotein-cholesterol, NAFLD nonalcoholic fatty liver disease
^* P < 0.05, compared with the NFT group. ^** P < 0.01, compared with the NFT group

ISSN: 1476-511X